Pharmaceuticals Related News
Farxiga granted Breakthrough Therapy Designation by FDA
Farxiga has been given Breakthrough Therapy Designation by the Food and Drug Administration (FDA) for patients with chronic kidney disease.
Farxiga has recently shown encouraging...
Could COVID-19 provide a new target for non-opioid pain relief?
COVID-19 could provide a new target for non-opioid pain relief according to new research, which has found that the virus can relieve pain.
The findings...
Combatting resistant depression with DMT and digital therapy
A wellbeing company is developing novel formulations of dimethyltryptamine (DMT) to help combat treatment resistant depression in combination with digital psychotherapy.
Nearly 264 million people live...
Cloud 9 Switzerland Group: nutraceuticals and pharmaceuticals
Life sciences company Cloud 9 Switzerland prioritises patient wellbeing, product quality and innovation in clinical practice.
Cloud 9 Switzerland is a life sciences company offering...
Opioid addiction warnings to be strengthened in UK
Regulators in the UK are strengthening opioid addiction and dependence warnings on patient information labels and leaflets.
The Medicines and Healthcare products Regulatory Agency (MHRA)...
Psychedelics association to bridge medical establishment and industry gap
Leaders in the field of psychedelic medicine have joined forces to create the global Psychedelic Medicine Association (PMA), which aims to bridge the gap...
Patient distrust in pharma companies sees launch of medication Trustpilot
A unique medication Trustpilot has been launched to help amplify patients voices as research reveals that 93% lack trust in pharmaceutical companies.
DrugsDisclosed.com has been launched...
Study shows metyrapone effective for treating rare Cushing’s Syndrome
The first ever prospective study to test the safety and efficacy of metyrapone in patients with Cushing’s Syndrome in a real-life setting has shown...
The Ketamine Conference: A Molecular Masterclass
The Ketamine Conference: A Molecular Masterclass is set to take place today, featuring a host of experts in the delivery of ketamine therapy for...
Graduate talent programme offered following COVID-19 disruptions
Many recent graduates across the world have had to put their dreams of entering the workforce on hold due to the COVID-19 pandemic, so...
Drug candidate as potential therapy for cytokine release syndrome
Preclinical proof of concept of PPP003 – a synthetic cannabinoid drug – has been put forward as potential therapy in the battle against COVID-19...
Could azithromycin prevent NHS workers from developing COVID-19?
Do you think azithromycin or doxycycline administered daily to frontline NHS workers prevent them from developing COVID-19? Researchers from the University of Salford tell...
How is the medical cannabis market disrupting the US healthcare industry?
In this article Global Market Insights discusses the impact of the medical cannabis market on the US healthcare industry.
Since the introduction of medical cannabis...
Pharma companies are more profitable than most S&P 500 companies
New research from Bentley University, Massachusetts, USA, reveals that big pharmaceutical companies are more profitable than most Standard & Poor (S&P) 500 companies.
The research...
Next generation pharmacology research with Tetra Bio-Pharma
Tetra Bio-Pharma are pleased to announce their co-development agreement with MAKScientific – could this agreement be the advancements needed for next generation pharmacology research?
Leaders...
ProPharma: seven things to consider in medical cannabis development
ProPharma Group takes a look at medical cannabis regulation and compliance.
Jan Zorgdrager, PhD, and Marc Stegeman, MSc, Principal Consultants in ProPharma Group’s Life Sciences...
European pharmaceutical industry’s shared goals and responsibilities
Nathalie Moll, Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA), explores Europe’s shared goals and shared responsibilities
When EU Commission President,...
How a cancer diagnosis inspired one of the fastest-emerging medical cannabis companies in the...
BBS Pharmaceuticals was born one night as two friends, Samuel Butler and Stuart Bais were driving back late from work.
“We started talking about a...
Curious to learn about antibiotic solution based on cannabinoids?
Pharmotech SA is a Swiss-based pharmaceutical company focused on the development of new antibiotic solutions based on cannabinoids.
The cannabinoids medical potential has been demonstrated...
Canngea’s mission to halt the global medicine shortage of cannabis
Currently, the supply of medical cannabis is not meeting the global demand, but could Canngea change this?
One company is aiming to put a halt...